These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27179966)

  • 1. Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
    Rasmussen H; Frokjaer VG; Hilker RW; Madsen J; Anhøj S; Oranje B; Pinborg LH; Glenthøj B; Knudsen GM
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1248-50. PubMed ID: 27179966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
    Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
    Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
    Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone.
    Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    Am J Psychiatry; 2000 Jun; 157(6):1016-8. PubMed ID: 10831488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trait aggression and trait impulsivity are not related to frontal cortex 5-HT2A receptor binding in healthy individuals.
    da Cunha-Bang S; Stenbæk DS; Holst K; Licht CL; Jensen PS; Frokjaer VG; Mortensen EL; Knudsen GM
    Psychiatry Res; 2013 May; 212(2):125-31. PubMed ID: 23137806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin 5-HT
    García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
    Hautzel H; Müller HW; Herzog H; Grandt R
    Neuroimage; 2011 Oct; 58(3):905-11. PubMed ID: 21722741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Baaré W; Holst KK; Mortensen EL; Arfan H; Madsen J; Jernigan TL; Kessing LV; Knudsen GM
    Neuropsychopharmacology; 2010 Apr; 35(5):1129-37. PubMed ID: 20043006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo 5-HT
    Radhakrishnan R; Matuskey D; Nabulsi N; Gaiser E; Gallezot JD; Henry S; Planeta B; Lin SF; Ropchan J; Huang Y; Carson RE; D'Souza DC
    Psychiatry Res Neuroimaging; 2020 Jan; 295():111007. PubMed ID: 31760336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain dopamine d1 receptors in twins discordant for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Am J Psychiatry; 2006 Oct; 163(10):1747-53. PubMed ID: 17012685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
    Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A
    Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined.
    Pinborg LH; Arfan H; Haugbol S; Kyvik KO; Hjelmborg JV; Svarer C; Frokjaer VG; Paulson OB; Holm S; Knudsen GM
    Neuroimage; 2008 Apr; 40(3):1175-80. PubMed ID: 18291676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Hietala J; Cannon TD
    Arch Gen Psychiatry; 2005 Apr; 62(4):371-8. PubMed ID: 15809404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2A receptor density is decreased in the at-risk mental state.
    Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
    Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia.
    Kouzmenko AP; Scaffidi A; Pereira AM; Hayes WL; Copolov DL; Dean B
    Hum Hered; 1999 Mar; 49(2):103-5. PubMed ID: 10077731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.